These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23431892)

  • 1. [Ketamine as an NMDA receptor antagonist].
    Kushikata T; Hirota K
    Masui; 2013 Jan; 62(1):38-43. PubMed ID: 23431892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine: repurposing and redefining a multifaceted drug.
    Potter DE; Choudhury M
    Drug Discov Today; 2014 Dec; 19(12):1848-54. PubMed ID: 25224017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression: comfortably numb.
    Check E
    Nature; 2006 Oct; 443(7112):629-31. PubMed ID: 17035973
    [No Abstract]   [Full Text] [Related]  

  • 5. The NMDA antagonist model for schizophrenia: promise and pitfalls.
    Abi-Saab WM; D'Souza DC; Moghaddam B; Krystal JH
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():104-9. PubMed ID: 9754841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological modulation of the effects induced by ketamine at subanesthetic doses].
    Mechri A; Micallef J; Blin O; Saoud M; Daléry J; Gaha L
    Therapie; 2001; 56(5):617-22. PubMed ID: 11806303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of NMDA receptor antagonists on visceromotor reflexes and on intestinal motility, in vivo.
    Shafton AD; Bogeski G; Kitchener PD; Sanger GJ; Furness JB; Shimizu Y
    Neurogastroenterol Motil; 2007 Jul; 19(7):617-24. PubMed ID: 17539896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NMDA receptor antagonist neurotoxicity and psychotomimetic activity].
    Nakao S; Nagata A; Masuzawa M; Miyamoto E; Yamada M; Nishizawa N; Shingu K
    Masui; 2003 Jun; 52(6):594-602. PubMed ID: 12854473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A reviewing for abusing of ketamine].
    Yang J; Bian SZ
    Fa Yi Xue Za Zhi; 2007 Aug; 23(4):312-5. PubMed ID: 17896530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action.
    Ficek J; Zygmunt M; Piechota M; Hoinkis D; Rodriguez Parkitna J; Przewlocki R; Korostynski M
    BMC Genomics; 2016 May; 17():362. PubMed ID: 27188165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effects of ketamine: neurotoxicity versus neuroprotection in anesthesia for the developing brain.
    Yan J; Jiang H
    J Neurosurg Anesthesiol; 2014 Apr; 26(2):155-60. PubMed ID: 24275940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression].
    Gosek P; Chojnacka M; Bieńkowski P; Swiecicki Ł
    Psychiatr Pol; 2012; 46(2):283-94. PubMed ID: 23214398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
    Lauterbach EC
    Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Suppressive effects of ketamine on neuropathic pain].
    Sonoda H; Omote K
    Masui; 1998 Feb; 47(2):136-44. PubMed ID: 9513324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methoxetamine: from drug of abuse to rapid-acting antidepressant.
    Coppola M; Mondola R
    Med Hypotheses; 2012 Oct; 79(4):504-7. PubMed ID: 22819129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine: a controversial drug for neonates.
    Bhutta AT
    Semin Perinatol; 2007 Oct; 31(5):303-8. PubMed ID: 17905185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
    Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
    Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans.
    Ilkjaer S; Petersen KL; Brennum J; Wernberg M; Dahl JB
    Br J Anaesth; 1996 Jun; 76(6):829-34. PubMed ID: 8679358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on "Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D(2) receptor".
    Krystal JH; D'Souza DC
    Biol Psychiatry; 2001 Oct; 50(7):555-6. PubMed ID: 11600110
    [No Abstract]   [Full Text] [Related]  

  • 20. The vasodilatory effect of ketamine is independent of the N-methyl-D-aspartate receptor: lack of functional N-methyl-D-aspartate receptors in rat mesenteric artery smooth muscle.
    Noh HJ; Bae YM; Park SH; Kim JG; Kim B; Kim YS; Kim SH; Cho SI; Woo NS
    Eur J Anaesthesiol; 2009 Aug; 26(8):676-82. PubMed ID: 19352184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.